RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재

    The Effects of Hominis Placenta Hydrate (HPH) on the Bone Marrow Failure Induced by 5-Fluorouracil

    한글로보기

    https://www.riss.kr/link?id=A103358355

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Aim: To examine the efficacy of Hominis Placenta Hydrate (HPH) on the hemopoiesis in a myelosuppression model system. Methods: Mice were injected with 5-Fluorouracil (5-FU) intraperitoneally and were administered with 200 mg/kg and 1000 mg/kg of HPH. Peripheral blood was analyzed at 5, 9, and 13 days. Histopathologic examination of bone marrow was performed at 5 days after 5-FU injection. The expression of cytokine involved in hemopoiesis was examined by using ELISA kit. Results: The hematology data demonstrated that the treatment of all the agents augmented monocytes and leucocytes counts in the peripheral blood WBC and platelet in HPH treated group were significant increased compared with control group. Also, cell numbers of RBC and Hb were restored. In HPH treated group, expression of IL-3, GM-CSF was significant increased But not TPO. Conclusions: Based on the above results, it is suggested that Hominis Placenta Hydrate is an effective remedy for the bone marrow failure and myelosuppression occurring during chemotherapy
    번역하기

    Aim: To examine the efficacy of Hominis Placenta Hydrate (HPH) on the hemopoiesis in a myelosuppression model system. Methods: Mice were injected with 5-Fluorouracil (5-FU) intraperitoneally and were administered with 200 mg/kg and 1000 mg/kg of HPH. ...

    Aim: To examine the efficacy of Hominis Placenta Hydrate (HPH) on the hemopoiesis in a myelosuppression model system. Methods: Mice were injected with 5-Fluorouracil (5-FU) intraperitoneally and were administered with 200 mg/kg and 1000 mg/kg of HPH. Peripheral blood was analyzed at 5, 9, and 13 days. Histopathologic examination of bone marrow was performed at 5 days after 5-FU injection. The expression of cytokine involved in hemopoiesis was examined by using ELISA kit. Results: The hematology data demonstrated that the treatment of all the agents augmented monocytes and leucocytes counts in the peripheral blood WBC and platelet in HPH treated group were significant increased compared with control group. Also, cell numbers of RBC and Hb were restored. In HPH treated group, expression of IL-3, GM-CSF was significant increased But not TPO. Conclusions: Based on the above results, it is suggested that Hominis Placenta Hydrate is an effective remedy for the bone marrow failure and myelosuppression occurring during chemotherapy

    더보기

    참고문헌 (Reference)

    1 "supports the growth of human multipotential progenitor cells with a high replating potential" 2216-21,

    2 "Thrombopoietin accelerates platelet red blood cell and neutrophil recovery in myelosuppressed mice" 24 : 1238-1246, 1996

    3 "The study on the Hominis Placenta Aqua acupuncture solution" 17 : 67-74, 2000

    4 "The effects of Saenghyuldan on the bone marrow failure" 22 : 33-45, 2001

    5 "Stem cell factor directly stimulate the development of enriched granulocyte macrophage colony forming cells and promotes the effects of other colony stimulating factors" 2230-6,

    6 "Simultaneous administration of TPO and G CSF after cytoreductive treatment of rhesus monkeysprevents thrombocytopenia accelerates platelet and red cell reconstitution alleviates neutropenia and promotes the recovery of immature bone marrow cells" 25 : 1084-1093, 1997

    7 "Signal Transduction Multiple pathways multiple options for therapy" 19 : 295-303, 2001

    8 "Self renewal differentiation or death regulation and manipulation of hematopoietic stem cell fate" 5 : 201-208, 1995

    9 "Recombinant human interleukin1 receptor antagonist protects early myeloid progenitors in a murine model of cyclophosphamide induced myelotoxicity" 85 : 2393-2401, 1995

    10 "Preventive effects of Hominis Placenta Extract on H2O2 Induced Apoptosis in Pineal Gland Cell Line" 18 : 69-78, 2001

    1 "supports the growth of human multipotential progenitor cells with a high replating potential" 2216-21,

    2 "Thrombopoietin accelerates platelet red blood cell and neutrophil recovery in myelosuppressed mice" 24 : 1238-1246, 1996

    3 "The study on the Hominis Placenta Aqua acupuncture solution" 17 : 67-74, 2000

    4 "The effects of Saenghyuldan on the bone marrow failure" 22 : 33-45, 2001

    5 "Stem cell factor directly stimulate the development of enriched granulocyte macrophage colony forming cells and promotes the effects of other colony stimulating factors" 2230-6,

    6 "Simultaneous administration of TPO and G CSF after cytoreductive treatment of rhesus monkeysprevents thrombocytopenia accelerates platelet and red cell reconstitution alleviates neutropenia and promotes the recovery of immature bone marrow cells" 25 : 1084-1093, 1997

    7 "Signal Transduction Multiple pathways multiple options for therapy" 19 : 295-303, 2001

    8 "Self renewal differentiation or death regulation and manipulation of hematopoietic stem cell fate" 5 : 201-208, 1995

    9 "Recombinant human interleukin1 receptor antagonist protects early myeloid progenitors in a murine model of cyclophosphamide induced myelotoxicity" 85 : 2393-2401, 1995

    10 "Preventive effects of Hominis Placenta Extract on H2O2 Induced Apoptosis in Pineal Gland Cell Line" 18 : 69-78, 2001

    11 "Oxford textbook of oncology" Oxford University Press Inc 4 : 445-453, 1995

    12 "Modulation of magakaryocytopoiesis by thrombopoietin The c mpl ligand" 86 : 1331-1338, 1995

    13 "MedicalImmunology" Simon & Schuster Company New jersey 9 : 146-167, 1997

    14 "Immunology" Mosby International Ltd 5 : 155-169, 1998

    15 "Hematopoietic stem cells for transplantation" 3 : 314-317, 2002

    16 "Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapy" 77-83,

    17 "Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents" 438-43, exphematol1993

    18 "Hematopoietic stem cell" 34 : 65-76, 2002

    19 "Granulocyte macrophage colony stimulating factor GM CSF priming of high dose etoposide and cyclophosphamide A pilot trial" 24 : 1363-1368, 1996

    20 "Granulocyte colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self renewal" 18 : 120-127, 2000

    21 "Graham Homing and mobilization in the stem cell niche" 9 : 233-238, 1999

    22 "Embryonic stem cell and nuclear transfer" 34 : 41-52, 2002

    23 "Effects of Placenta Hominis on the sex hormon content and lipid content in the ovariectomized rats" 14 : 103-117, 2001

    24 "Effect of c-kit ligand on in vivo human megakaryocytopoiesis" 2854-9,

    25 "Effect of Hominis Placenta on the ovariectomised osteoporotic rats" 16 : 213-221, 1999

    26 "Cytokine manipulation of primitive human hematopoietic cell self renewal" 94 : 4698-4703, 1997

    27 "Cyclophosphamide granulocyte colony stimulating factor induce hematopoietic stem cells to proliferate prior to mobilizatio" 94 : 1908-1913, 1996

    28 "Current trends of stem cell research using pluripotent stem Cells" 34 : 7-21, 2002

    29 "Bone marrow stem cell protection from chemotherapy by low molecular weight compounds" 29 : 123-137, 2001

    30 "Accelerated recovery from cyclophosphamide induced leukopenia in mice administered a Japanese ethical herbal drug Hochu ekkii to" 44 : 223-231, 1999

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2022 평가 재인증평가 신청대상 (재인증)
    2019-01-01 등재 등재학술지 유지 (계속평가) KCI등재
    2016-01-01 등재 등재학술지 선정 (계속평가) KCI등재
    2015-12-01 등재 등재후보로 하락 (기타) KCI등재후보
    2011-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2009-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2006-02-09 학술지명변경 외국어명 : THE KOREAN SOCIETY FOR ORIENTAL INTERNAL MEDICINE -> The Journal of Korean Oriental Internal Medicine KCI등재
    2006-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2005-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2003-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.67 0.67 0.61
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.56 0.5 0.653 0.03
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼